Literature DB >> 17288739

Acute neurovascular unit protection by simvastatin in transient cerebral ischemia.

Tavarekere N Nagaraja1, Robert A Knight, Richard L Croxen, Kirthi P Konda, Joseph D Fenstermacher.   

Abstract

Acute vascular- and neuroprotective effects of simvastatin were evaluated in a rat model of transient, focal cerebral ischemia. Male, Wistar rats (n=12) underwent transient middle cerebral artery (MCA) occlusion for 3 hours followed by 3 hours of reperfusion. After 30 minutes of MCA occlusion, four rats each were subcutaneously injected with either 20 or 40 mg/kg of simvastatin. At the end of 3 hours of reperfusion, tissue injury and blood-brain barrier (BBB) opening were quantified by histology and [(14)C]-alpha-aminoisobutyric acid (AIB)-based quantitative autoradiography (QAR), respectively. Compared with untreated rats, those treated with simvastatin (20 mg/kg) had reduced volumes of AIB leakage, tissue pallor and distribution space for AIB (p<0.05). No additional effects were seen with the higher drug dose (40 mg/kg). These data suggest that the acute neuroprotective effects of statins are in part owing to attenuation of stroke-induced changes in BBB permeability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17288739     DOI: 10.1179/174313206X153914

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  10 in total

1.  A Prospective Safety Trial of Atorvastatin Treatment to Assess Rebleeding after Spontaneous Intracerebral Hemorrhage: A Serial MRI Investigation.

Authors:  R A Knight; T N Nagaraja; L Li; Q Jiang; K Tundo; M Chopp; D M Seyfried
Journal:  Austin J Cerebrovasc Dis Stroke       Date:  2016-07-20

2.  Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke.

Authors:  Andria L Ford; Hongyu An; Gina D'Angelo; Rosana Ponisio; Patrick Bushard; Katie D Vo; William J Powers; Weili Lin; Jin-Moo Lee
Journal:  Stroke       Date:  2011-03-31       Impact factor: 7.914

3.  An association of prior statin use with decreased perihematomal edema.

Authors:  Neeraj S Naval; Tamer A Abdelhak; Nathalie Urrunaga; Paloma Zeballos; Marek A Mirski; Juan R Carhuapoma
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

Review 4.  Nitric oxide: considerations for the treatment of ischemic stroke.

Authors:  Nicole A Terpolilli; Michael A Moskowitz; Nikolaus Plesnila
Journal:  J Cereb Blood Flow Metab       Date:  2012-02-15       Impact factor: 6.200

5.  Simvastatin blocks blood-brain barrier disruptions induced by elevated cholesterol both in vivo and in vitro.

Authors:  Xijuan Jiang; Maojuan Guo; Jinling Su; Bin Lu; Dongming Ma; Ruifeng Zhang; Lin Yang; Qiang Wang; Yiwen Ma; Yingchang Fan
Journal:  Int J Alzheimers Dis       Date:  2012-02-01

6.  Persimmon leaf flavonoid promotes brain ischemic tolerance.

Authors:  Mingsan Miao; Xuexia Zhang; Ming Bai; Linan Wang
Journal:  Neural Regen Res       Date:  2013-10-05       Impact factor: 5.135

Review 7.  Treatment of acute cerebral ischemia using animal models: a meta-analysis.

Authors:  Peng-Fei Wang; Yu Zhou; Huang Fang; Sen Lin; Yan-Chun Wang; Yong Liu; Jun Xia; Guy D Eslick; Qing-Wu Yang
Journal:  Transl Neurosci       Date:  2015-02-11       Impact factor: 1.757

8.  Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage.

Authors:  Lilla Barna; Fruzsina R Walter; András Harazin; Alexandra Bocsik; András Kincses; Vilmos Tubak; Katalin Jósvay; Ágnes Zvara; Patricia Campos-Bedolla; Mária A Deli
Journal:  Fluids Barriers CNS       Date:  2020-02-10

9.  Redox Regulation of Microvascular Permeability: IL-1β Potentiation of Bradykinin-Induced Permeability Is Prevented by Simvastatin.

Authors:  Felipe Freitas; Eduardo Tibiriçá; Mita Singh; Paul A Fraser; Giovanni E Mann
Journal:  Antioxidants (Basel)       Date:  2020-12-14

10.  Increasing Ang1/Tie2 expression by simvastatin treatment induces vascular stabilization and neuroblast migration after stroke.

Authors:  Jieli Chen; Xu Cui; Alex Zacharek; Michael Chopp
Journal:  J Cell Mol Med       Date:  2008-06-09       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.